GLP-1 TV · Clinician
Not Losing Weight on Wegovy? Uncovering the Reasons Behind Non-Response | Dr. Dan | Obesity Expert
Today’s cheapest Wegovy$208/mo at Sesame Care, an average: a $59/mo subscription billed $708 once a year, with medication billed monthly.Compare all Wegovy prices Price read 22 Nov 2026 from the seller’s own page, ranked by price alone. Not from the video’s creator.Our summary
The speaker, who presents as an obesity expert, explains why some people taking Wegovy or Zepbound do not lose weight. He says researchers count a loss of more than 5% of baseline weight as a successful response, and that in the STEP 1 and SURMOUNT 1 trials roughly 10 to 15% of participants did not reach that mark. He says he sees a similar rate in his own practice.
Published by Dr. Dan | Obesity Expert on YouTube
As published by the channel. Not medical advice, and not an endorsement.
What else the video covers
He sorts the people he sees into three groups. True nonresponders get no appetite or craving reduction at all, which he compares to taking a placebo. He says the cause is unclear but likely involves genetics and individual biology, and that some of these patients respond after a switch from Wegovy to Zepbound or to Contrave. Slow responders do get appetite effects but lose weight at a lower pace, such as 1 to 2 lb per month compared with 4 to 8 lb. He links this to genetics, conditions such as diabetes or mental health concerns, weight-promoting medications, a history of yo-yo dieting, consistency of about 60 to 70% instead of 80%, and slower dose titration because of side effects. Quick Fix Seekers, in his view, mainly need education and compassion.
On expectations, he says an average of about 1 lb per week (half a pound to 2 lb) is typical and that some weeks show no loss. He adds that the medications are not magic, that the trials told participants to eat in a calorie deficit and be more active, and that effort will not match results proportionally because of evolutionary biology and today's food environment. He concludes that the drugs are a tool, and that patience and consistency matter most. The video also includes promotion for his consultations, membership, and channel.
Our summary of what is said, in our words. Doses, results and prices are the speaker’s, not advice.
Takeaways
The main points, in the order they come up. Tap a time to play from there.
- 0:00 The speaker says weight loss of more than 5% of baseline counts as a response, and about 10 to 15% of people in the STEP 1 and SURMOUNT 1 trials fell short of it.
- 1:31 He describes true nonresponders as people who get no appetite suppression, and says some respond after switching between Wegovy, Zepbound or Contrave.
- 3:01 He describes slow responders as people who lose about 1 to 2 lb per month, with causes such as genetics, comorbid conditions, yo-yo dieting, inconsistency or slow dose titration.
- 5:04 He says Quick Fix Seekers need education and realistic expectations, with about 1 lb per week as the average loss.
- 7:35 He says the medications are not magic and that the studies had participants follow a calorie deficit and increase activity.
- 11:05 He concludes that the drugs are a tool and that patience and consistency are the key to success.
Key moments
Tap one to play from there.
What the video says
As stated in the video, not checked by us. Doses and results are the speaker’s, not advice.
- Medication
- Wegovy
Questions this video answers
What percentage of people don't respond to Wegovy or Zepbound?
According to the speaker, about 10 to 15% of people in the STEP 1 and SURMOUNT 1 trials did not lose at least 5% of their baseline weight. He says clinical practice shows a similar result.
Why am I not losing weight on Wegovy?
The speaker describes three groups: true nonresponders with no appetite effect, slow responders affected by factors like genetics, other conditions, inconsistency or slow dose titration, and people with unrealistic expectations. He says the cause of true non-response is not well understood.
How much weight should I expect to lose per week on these medications?
The speaker says the expectation is about half a pound to 2 lb per week, averaging around 1 lb per week or roughly 4 lb per month, with some weeks showing no loss. He says expecting much more is a recipe for failure.
Can switching medications help if Wegovy isn't working?
The speaker says some people who did not respond to Wegovy responded after switching to Zepbound, or to Contrave, which works by a different mechanism. He adds that some people respond to none of them and may need to wait for newer agents.
Videos on the same question
The closest videos in the library by what is said in them, not by title.
7.2mg Wegovy Results: Should You Be Worried?In this video, the speaker, who describes himself as an obesity expert, discusses a new post hoc analysis of the STEP UP trial, a randomized controlled trial of high-dose Wegovy up to 7.2 mg once a week.- What Wegovy costs at every program we trackToday’s lowest is $208/mo. Every program ranked by price alone.
MOUNJARO/ZEPBOUND for weight loss: Study findings on “slow responders”The speaker, who says she has used Mounjaro (tirzepatide) for over a year and a half, reads and comments on a MedPage Today article by Ed Silverman, dated May 10, 2024.
How to Safely Come Off Wegovy: Decoding the Transition | Dr. Dan | Obesity ExpertThe speaker, an obesity expert, explains how he would help a patient stop a medication like Wegovy or Zepbound while trying to keep the weight off.
Wegovy & Ozempic: The Ins & Outs of Weight Loss Drugs | Mark Moyad, MD & Mark Scholz, MD | PCRIIn this short conversation, the speaker, MD and the speaker, MD discuss the GLP-1 agonist class of weight loss drugs.
Read next
Our guides closest to what this video covers, with prices checked weekly.
- Who qualifies for Wegovy and Zepbound? The BMI rules, the conditions, and what your plan adds
You qualify for Wegovy or Zepbound for weight loss as an adult with a BMI of 30 or more, or 27 or more with a weight-related condition such as high blood pressure or high cholesterol. Wegovy also treats adults with heart disease at BMI 27 and up, and a liver disease called MASH; Zepbound also treats sleep apnea at BMI 30 and up. Insurers often ask for more: Aetna's 2026 policy wants BMI 35 and six months in a weight program, and Medicare's Bridge wants BMI 35, or 30 or 27 with specific conditions.
- How long do Ozempic, Wegovy and Zepbound take to work? The label calendar and the trial timepoints
GLP-1s act from the first dose, but the labels start low on purpose and step up every 4 weeks, so most people do not reach a full dose for 3 to 5 months. Each dose reaches steady levels in the blood after about 4 to 5 weeks. In the trials, people averaged 10.6% weight loss after 20 weeks of Wegovy's escalation and 20.9% after 36 weeks of Zepbound, with the full trial results at 68 to 72 weeks. For type 2 diabetes, Ozempic's A1C results were measured at week 30.
- Zepbound vs Wegovy: the two weight-loss brands, priced every way you can buy them
Zepbound is tirzepatide and Wegovy is semaglutide, and in the one trial that ran them head-to-head, tirzepatide's molecule lost 20.2% of body weight against 13.7% over 72 weeks. That settles which is stronger. What it does not settle is which you can afford: Zepbound self-pay runs $299 to $699 a month by dose, Wegovy's pen is $349 flat and its new tablet starts at $149, and with a commercial plan that covers either, both fall to $25.
Next steps
Wegovy prices
Find more like it
Dose changeWeigh-in and resultsFood noise and cravingsStopping and maintenanceHow it worksThe trials
Up next
More from this collection
Watched it? See what it costs.
Every GLP-1 program we track, ranked by what actually leaves your account.




















